Simple and robust approach for breast cancer risk assessment
PREVENT is an innovative approach designed for all healthy women, regardless of ethnicity, particularly those not at increased risk of carrying a BRCA gene mutation.
This solution provides physicians with a more precise estimation of breast cancer risk and supports personalized screening plans.
PREVENT is a an extremely robust approach, based on over a decade of research and hundreds of thousands of subjects.
For Research Use Only. Not for use in diagnostic procedures.
Simple steps for physicians
Data analysis by SOPHiA
SOPHiA combines and analyzes information from three risk categories and generates a powerful breast cancer risk estimate, which can be used to compare a woman’s risk to that of the general population.
Frequent genetic variations
SNP* constellation strongly associated with breast cancer risk
Non-modifiable risk factors
such as family history of breast cancer and reproductive history
Modifiable risk factors
including body mass index and level of alcohol consumption
*SNP: Single Nucleotide Polymorphism - Frequent genetic variants
Dr. Jonathan Krell, Consultant Medical Oncologist at Imperial College London Healthcare NHS Foundation Trust
Minimally invasive approach
Supported by clinical data
Compliant with privacy guidelines
Identifies women that are at increased risk
In this webinar, Pr. Xavier Pivot, General Director of the Paul Strauss Center, will describe the clinical utility of PREVENT, and how it will fit into the breast cancer program at the Paul Strauss Center.